Valuation (0%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | N/A | N/A |
PEG Ratio (TTM) | N/A | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | N/A | N/A |
P/FCF Ratio (TTM) | N/A | N/A |
Price to 5YR AVG Earnings Ratio | -0.01 | N/A |
Price to 5YR AVG FCF Ratio | -0.31 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | N/A | N/A |
ROE (TTM) | N/A | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | -8.73% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -140.21% | -147.66% | -267.33% |
Revenue | -29.56% | -9.03% | -14.79% |
Net Income | -153.37% | -134.72% | -240.11% |
Cash Flow | -21.87% | -27.82% | -1,165.45% |
Health (16%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | N/A | N/A |
Quick Ratio (TTM) | N/A | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -17.71 | N/A |
Shares Outstanding Growth 5YR AVG | -6.75% | N/A |